Item | Information |
---|---|
CAS RN | 823-40-5 |
Chemical Name | 2-methyl-m-phenylene diamine |
Substance ID | m-nite-823-40-5_v2 |
Download of Excel format | Excel file |
Item | Information |
---|---|
Guidance used for the classification (External link) | To Guidance List |
UN GHS document (External link) | To UN GHS document |
FAQ(GHS classification results by the Japanese Government) | To FAQ |
List of Information Sources (Excel file) | List of Information Sources |
List of Definitions/Abbreviations | Definitions/Abbreviations |
Sample Label by MHLW (External link) | MHLW Website (in Japanese Only) |
Sample SDS by MHLW (External link) | MHLW Website (in Japanese Only) |
OECD/eChemPortal (External link) | To OECD/eChemPortal (External link) |
Hazard class | Classification | Pictogram Signal word |
Hazard statement (code) |
Precautionary statement (code) |
Rationale for the classification | Classification year (FY) | GHS Classification Guidance for the Japanese Government | |
---|---|---|---|---|---|---|---|---|
1 | Explosives | - |
- |
- | - | - | - | - |
2 | Flammable gases | - |
- |
- | - | - | - | - |
3 | Aerosols | - |
- |
- | - | - | - | - |
4 | Oxidizing gases | - |
- |
- | - | - | - | - |
5 | Gases under pressure | - |
- |
- | - | - | - | - |
6 | Flammable liquids | - |
- |
- | - | - | - | - |
7 | Flammable solids | - |
- |
- | - | - | - | - |
8 | Self-reactive substances and mixtures | - |
- |
- | - | - | - | - |
9 | Pyrophoric liquids | - |
- |
- | - | - | - | - |
10 | Pyrophoric solids | - |
- |
- | - | - | - | - |
11 | Self-heating substances and mixtures | - |
- |
- | - | - | - | - |
12 | Substances and mixtures which, in contact with water, emit flammable gases | - |
- |
- | - | - | - | - |
13 | Oxidizing liquids | - |
- |
- | - | - | - | - |
14 | Oxidizing solids | - |
- |
- | - | - | - | - |
15 | Organic peroxides | - |
- |
- | - | - | - | - |
16 | Corrosive to metals | - |
- |
- | - | - | - | - |
17 | Desensitized explosives | - |
- |
- | - | - | - | - |
Hazard class | Classification | Pictogram Signal word |
Hazard statement (code) |
Precautionary statement (code) |
Rationale for the classification | Classification year (FY) | GHS Classification Guidance for the Japanese Government | |
---|---|---|---|---|---|---|---|---|
1 | Acute toxicity (Oral) | Classification not possible |
- |
- | - | Classification is not possible because there is no data. In addition, 2,5-TDA, and 2,4-TDA are equivalent to Category 3. [NOTE] See the classification results of 2,4-TDA (2,4-toluene diamine, ID167, CAS: 95-80-7), 2,5-TDA (paratoluylenediamime, ID1324, CAS: 95-70-5)), TDA (Toluylenediamine, ID1309, CAS: 25376-45-8) which is a collective term for TDA constitutional isomer. For this harmful effect for the health, the classification result of these isomers is indicated as needed. | FY2007 | GHS Classification Manual (10 Feb, 2006)/Technical Guidance Document on the GHS Classification (6 Dec, 2005) |
1 | Acute toxicity (Dermal) | Classification not possible |
- |
- | - | Classification is not possible because there is no data. In addition, 2,5-TDA cannot be classified, and 2,4-TDA is Category 3. | FY2007 | GHS Classification Manual (10 Feb, 2006)/Technical Guidance Document on the GHS Classification (6 Dec, 2005) |
1 | Acute toxicity (Inhalation: Gases) | Not classified (Not applicable) |
- |
- | - | Since it was a solid by the definition of GHS, it was classified into "Not applicable". | FY2007 | GHS Classification Manual (10 Feb, 2006)/Technical Guidance Document on the GHS Classification (6 Dec, 2005) |
1 | Acute toxicity (Inhalation: Vapours) | Classification not possible |
- |
- | - | Classification not possible due to lack of data | FY2007 | GHS Classification Manual (10 Feb, 2006)/Technical Guidance Document on the GHS Classification (6 Dec, 2005) |
1 | Acute toxicity (Inhalation: Dusts and mists) | Classification not possible |
- |
- | - | Classification not possible due to lack of data | FY2007 | GHS Classification Manual (10 Feb, 2006)/Technical Guidance Document on the GHS Classification (6 Dec, 2005) |
2 | Skin corrosion/irritation | Category 2 |
Warning |
H315 | P302+P352 P332+P313 P362+P364 P264 P280 P321 |
Although there is no skin irritation test data of this substance, it has been described that this substance has a "skin irritation" in ICSC (2001) or that "Diaminotoluene irritates skin" in EHC 74 (1987). It may be classified as Category 2 or Category 3 since it is likely to have an irritation despite its unknown degree. It is classified into Category 2 from a viewpoint of safety. In addition, 2,5-TDA and 2,4-TDA can be classified as Category 3. | FY2007 | GHS Classification Manual (10 Feb, 2006)/Technical Guidance Document on the GHS Classification (6 Dec, 2005) |
3 | Serious eye damage/eye irritation | Category 2 |
Warning |
H319 | P305+P351+P338 P337+P313 P264 P280 |
Although there is no data of the eye irritation test of this substance, it has been described that the substance is "eye-irritative" in ICSC (2001), or that "Diaminotoluene irritates eyes" in EHC 74 (1987). Although the level is unknown, since it is considered to own irritation, it is classified into Category 2. In addition, 2,5-TDA is Category 2A-2B and 2,4-TDA are Category 2A. | FY2007 | GHS Classification Manual (10 Feb, 2006)/Technical Guidance Document on the GHS Classification (6 Dec, 2005) |
4 | Respiratory sensitization | Classification not possible |
- |
- | - | Classification is not possible since there is no data. | FY2007 | GHS Classification Manual (10 Feb, 2006)/Technical Guidance Document on the GHS Classification (6 Dec, 2005) |
4 | Skin sensitization | Classification not possible |
- |
- | - | It can be classified as R43 in EU-Annex I which is the source of information of Priority2, and it has been described in ICSC (2001) which is the source of information of Priority2 in the same way that skin may be sensitized by the repeated or long-term contact." However, it was classified into "Classification not possible" because of no data of concrete epidemiologic survey, case report, and animal experiment. In addition, 2,5-TDA, 2,4-TDA, and TDA are Category 1. | FY2007 | GHS Classification Manual (10 Feb, 2006)/Technical Guidance Document on the GHS Classification (6 Dec, 2005) |
5 | Germ cell mutagenicity | Not classified |
- |
- | - | Although there are very weak positive findings (Carcinogenesis, 12, 2233-2237, 1991) in rat bone marrow micronucleus tests as a result of investigation not only on the information source of Priority 1, 2, it was defined as "Not classified" from the weight of the evidence based on two negative findings in the mutation assays employing transgenic mice (Environ Health Perspect, 104 (Suppl 3), 683-686, 1996; Mutat Res, 608,88-96, 2006) and the negative results in rat liver UDS tests (Carcinogenesis,12, 2233-2237,1991). Moreover, although 2,4-TDA is defined as "Not classified" as a result of the previous classification, a positive result has been obtained in the above mutation assays employing transgenic mice, and it is classified into Category 2. | FY2007 | GHS Classification Manual (10 Feb, 2006)/Technical Guidance Document on the GHS Classification (6 Dec, 2005) |
6 | Carcinogenicity | Not classified |
- |
- | - | There is no existing classification. On the other hand, EHC 74 (1987) cited the 103-week oral administration test employing rats and mice by NCI (1980). EHC is saying that "NCI (1980) concluded that 2,6-TDA does not show carcinogenicityity to F344 rat of male and female, and B6C3F1 mouse of male and female" based on various statistical evaluations, and the reliability of the data of NCI can be evaluated. Therefore, the conclusion of NCI was adopted and it was carries out "Not classified". In addition, in a three-ministry GHS classification, 2,5-TDA is "Not classified", 2,4-TDA and TDA are in Category 2. | FY2007 | GHS Classification Manual (10 Feb, 2006)/Technical Guidance Document on the GHS Classification (6 Dec, 2005) |
7 | Reproductive toxicity | Category 2 |
Warning |
H361 | P308+P313 P201 P202 P280 P405 P501 |
Since embryonic death has been identified at the dose level where decrease in the body weight of mother animals is identified in the oral administration study using rabbits in the description of EHC 74 (1987), it is classified in Category 2. In addition, since increase of imperfect spinal segments development in fetuses at the dose level where the body weight reduction of mother animals is not identified is identified in the oral administration study using rats published in EHC 74 (1987), which corresponds to a skeletal variant, GHS is considered to correspond to Category 2. Moreover, strenebrae deficiencies and imperfect closure of skulls have been observed at the dose level where the body weight reduction in mother animals is observed. 2.5-TDA, 2.4-TDA and TDA are all Category 2. | FY2007 | GHS Classification Manual (10 Feb, 2006)/Technical Guidance Document on the GHS Classification (6 Dec, 2005) |
8 | Specific target organ toxicity - Single exposure | Category 2 (blood system), Category 3 (respiratory tract irritation, narcotic effects) |
Warning |
H371 H335 H336 |
P308+P311 P260 P264 P270 P405 P501 P304+P340 P403+P233 P261 P271 P312 |
About humans, ICSC (J) (2001) which is the information source of Priority2, have descriptions of "cough, dizziness, headache, shortness of breath, confusion, spasm, nausea, and deliquium animi" as acute symptoms by inhalation exposures, and that "airway is stimulated. Blood may be affected and a methemoglobin may be generated" as effects of short durations exposures. Therefore, it was considered to have Respiratory tract irritation and Narcotic effects, and its target organ was the blood systems. As mentioned above, the category was taken as Category 2 (blood system) and Category 3 (Respiratory tract irritation, Narcotic effects). | FY2007 | GHS Classification Manual (10 Feb, 2006)/Technical Guidance Document on the GHS Classification (6 Dec, 2005) |
9 | Specific target organ toxicity - Repeated exposure | Classification not possible |
- |
- | - | Classification is not possible because there is no data. In addition, 2,5-TDA cannot be classified, and 2,4-TDA is classified as Category 1 (liver, kidney), Category 2 (blood system, lien, testis). TDA is classified as Category 1 (liver). | FY2007 | GHS Classification Manual (10 Feb, 2006)/Technical Guidance Document on the GHS Classification (6 Dec, 2005) |
10 | Aspiration hazard | Classification not possible |
- |
- | - | Classification not possible due to lack of data | FY2007 | GHS Classification Manual (10 Feb, 2006)/Technical Guidance Document on the GHS Classification (6 Dec, 2005) |
Hazard class | Classification | Pictogram Signal word |
Hazard statement (code) |
Precautionary statement (code) |
Rationale for the classification | Classification year (FY) | GHS Classification Guidance for the Japanese Government | |
---|---|---|---|---|---|---|---|---|
11 | Hazardous to the aquatic environment Short term (Acute) | Classification not possible |
- |
- | - | No data available. | FY2021 | GHS Classification Guidance for the Japanese Government (FY2019 revised edition (Ver. 2.0)) |
11 | Hazardous to the aquatic environment Long term (Chronic) | Classification not possible |
- |
- | - | No data available. | FY2021 | GHS Classification Guidance for the Japanese Government (FY2019 revised edition (Ver. 2.0)) |
12 | Hazardous to the ozone layer | Classification not possible |
- |
- | - | This substance is not listed in the Annexes to the Montreal Protocol. | FY2021 | GHS Classification Guidance for the Japanese Government (FY2019 revised edition (Ver. 2.0)) |
|